Results 161 to 170 of about 75,131 (308)

Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients. [PDF]

Int J Gen Med, 2023
Adil SO, Uddin F, Musa KI, Khan A, Shakeel A, Shafique K, Islam MA.   +6 more
europepmc   +1 more source

Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study [PDF]

, 2016
Background Chronic kidney disease is an important cause of global mortality and morbidity. Data for epidemiological features of chronic kidney disease and its risk factors are limited for low-income and middle-income countries.
Bikbov, Boris, Carminati, Sergio, Ene-Iordache, Bogdan, Flores Bravo, Rodolfo, Islam, Nazmul, Perico, Norberto, Perna, Annalisa, Remuzzi, Andrea   +7 more
core  

PCV147 Framingham Risk Score in Health Economic Modelling: A European Perspective [PDF]

, 2011
P. Carlqvist, Jonas Hermansson, E. Moorcroft, R. Hettle   +3 more
openalex   +1 more source

A Longitudinal Study Reveals Metabolomic Markers for Individuals at Risk, Disease Severity, and Treatment Response in Rheumatoid Arthritis

Advanced Science, Volume 12, Issue 38, October 13, 2025.
This study investigates plasma metabolomic biomarkers for rheumatoid arthritis (RA) development using longitudinal data from 209 RA patients and 56 individuals at risk. It also reveals metabolic signatures linked to severity, age, sex, and anti‐citrullinated protein autoantibody in RA.
Chenxi Zhu, Jiayi Xu, Siyu He, Qian Niu, Yi Liu, Xin Guo, Huifang Hu, Rui Sun, Tao Chen, Yan Liu, Zhiqiang Xu, Na Jiang, Lipu Yao, Lunzhi Dai, Qinghua Zou, Fanxin Zeng, Liesu Meng, Inger Gjertsson, Rikard Holmdahl, Bin Yang, Dan Du, Yi Zhao   +21 more
wiley   +1 more source

High Concordance between D:A:Dr and the Framingham Risk Score in Brazilians Living with HIV. [PDF]

Viruses, 2023
Souza V, Valadares V, Dias T, Brites C.
europepmc   +1 more source

Enhancing the Framingham Risk Score for coronary heart disease by adding information on working hours [PDF]

, 2011
Michelle M. Graham
openalex   +1 more source

Independent effects of white matter lesion volume and APOE ɛ4 on ARIA‐H in A4 Study

Alzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION Increased white matter hyperintensity (WMH) volume is a common but non‐specific finding in AD. This study investigates the effect of baseline WMH volume and APOE ε4 on magnetic resonance imaging (MRI)‐visible hemorrhagic lesion emergence.
Zahra Shirzadi, Aaron P. Schultz, Nazila Loghmani, Hyun‐Sik Yang, Jeremy Ford, Roy Yaari, Michael Properzi, Wai‐Ying W. Yau, Lei Liu, Michael S. Rafii, Michael C. Donohue, Adam M. Brickman, Clifford R. Jack Jr, Steven M. Greenberg, Paul Aisen, Reisa A. Sperling, Jasmeer P. Chhatwal, the A4 Study Team   +17 more
wiley   +1 more source

Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran. [PDF]

BMC Cardiovasc Disord, 2023
Saki N, Babaahmadi-Rezaei H, Rahimi Z, Raeisizadeh M, Jorfi F, Seif F, Cheraghian B, Ghaderi-Zefrehi H, Rezaei M.   +8 more
europepmc   +1 more source

Impact of regional white matter hyperintensity patterns on cognitive trajectories in NACC

Alzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION White matter hyperintensities (WMHs) are a biomarker of small vessel cerebrovascular changes that can emerge early in Alzheimer's disease. While global WMHs correlate with cognitive decline, the impact of regional WMHs remains understudied.
Lindsay J. Rotblatt, Lauren Edwards, Fareshte Erani, Caitlin M. Terao, Katherine J. Bangen, Kelsey R. Thomas   +5 more
wiley   +1 more source

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts

Alzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION It remains unclear whether diabetes mellitus (DM) is associated with Alzheimer's disease (AD) pathology and associated vascular burden. METHODS We included cognitively normal (CN), mild cognitive impairment (MCI), and dementia individuals. We assessed associations between DM and AD biomarkers (amyloid beta [Aβ], phosphorylated tau‐
Veerle van Gils, Willemijn J. Jansen, Wiesje M. van der Flier, Pablo Martinez‐Lage, Jakub Hort, Inez H. G. B. Ramakers, Olivier Rouaud, Markku Laakso, Sebastiaan Engelborghs, Julius Popp, Alberto Lleó, Anders Wallin, Magda Tsolaki, Charlotte E. Teunissen, Rik Vandenberghe, Yvonne Freund‐Levi, Lutz Frölich, Henrik Zetterberg, Johannes Streffer, Simon Lovestone, Justine Moonen, Argonde van Harten, Katerina Veverová, Nienke Legdeur, Anouk den Braber, Daniel Damian, Anette Hall, Janita Bralten, Giuseppe Fanelli, Barbara Franke, Geert Poelmans, Monica Bulló, Susana Jimenez‐Murcia, Fernando Fernandez‐Arande, Jordi Salas Salvadó, Søren Dalsgaard, Pieter Jelle Visser, Stephanie J. B. Vos   +37 more
wiley   +1 more source